Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic

Area of Science:

• Neuroscience
• Translational Research
• Drug Discovery

Background:

• Brain diseases cause significant global death and disability.
• Despite advances in understanding brain disorders and drug discovery, effective treatments remain limited.
• Translational neuroscience research faces challenges in bridging basic discovery and clinical application.

Purpose of the Study:

• To discuss how lessons from the COVID-19 pandemic can advance translational neuroscience research.
• To emphasize patient-centered approaches and collaborative risk mitigation in research.
• To explore the role of open science and publishing in accelerating therapeutic development.

Main Methods:

• Expansion on Keystone Symposia panel discussions on translational neuroscience.
• Analysis of pandemic-related lessons for research collaboration.
• Discussion of open innovation models in scientific publishing.

Main Results:

• Efficient collaboration is key to bridging the gap between basic discovery and clinical application.
• Patient-centered research paradigms and shared risk mitigation are essential.
• Open science journals can accelerate progress by fostering data and knowledge exchange.

Conclusions:

• Urgent need to advance brain disease therapies through collaborative efforts.
• Integrating lessons from the COVID-19 pandemic can catalyze progress in translational research.
• Open innovation and scientific publishing play crucial roles in translating discoveries into effective treatments.